SYSTEMATIC REVIEW article
Front. Nutr.
Sec. Clinical Nutrition
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1575580
This article is part of the Research TopicExploring the Impact of Nutrition and Physical Activity on Sarcopenic ObesityView all 9 articles
Exercise interventions of ≥8 weeks improve body composition, physical function, metabolism, and inflammation in older adults with stage I sarcopenic obesity: a systematic review and meta-analysis
Provisionally accepted- 1Beijing Sport University, Beijing, China
- 2School of Sports and Human Sciences, Beijing Sport University, Beijing, Beijing Municipality, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
This study aimed to assess the benefits of 8-week-plus exercise interventions for stage I sarcopenic obesity (SO) without complications. Randomized controlled trials (RCTs) from 2004 to July 2024 were searched in PubMed, Embase, Web of Science, Cochrane Library, and EBSCO. Publication bias was assessed via funnel plots and Egger's test; heterogeneity (I² >50%) was managed with random-effects models. Fifteen parallel-group RCTs involving 623 elderly (≥60 years) patients were included. The results showed that exercise significantly reduced BMI (MD = -0.58, P < 0.0001), with combined exercise (CE) most effective (MD = -0.67, P < 0.0001). Body fat percentage decreased (MD = -0.52, P < 0.00001), with CE outperforming resistance training (RT). No significant changes in fat mass or muscle mass indices were found (fat mass: P = 0.19; appendicular skeletal muscle mass: P = 0.88; appendicular skeletal muscle mass index: P = 0.86). Physical function (grip strength, gait speed, timed Up and Go test) improved significantly (P < 0.00001); RT and CE enhanced muscle strength, with RT superior (MD= 3.43 vs. 2.64, both P < 0.00001). Additionally, CE lowered insulin (MD = -1.73, P < 0.05) and total cholesterol (MD = -11.07, P < 0.05), with marginal IL-6 reduction (MD = -0.51, P = 0.08); other metabolic and inflammatory markers (glucose, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, tumor necrosis factor-α, and C-reactive protein) were unchanged. Overall, these data indicate that 8-week-plus exercise improves body composition in stage I SO, with CE superior for fat loss. Functional indices improve with both RT and CE, and RT is better for muscle strength; CE benefits metabolism and inflammation. We recommend that CE (≥3 times/week, 45 minutes/session, including aerobic exercise and RT) for high inflammation and RT (2 times/week, 60%-80% 1-RM) for low inflammation. Based on observed data trends, promoting a CE model of 3 AR + 2 RT sessions weekly is advisable, with intensity adjusted to 40%-50% 1-RM for elderly patients. Future research needs large-sample, long-term RCTs with subgroup analyses and exercise-nutrition combinations.
Keywords: Exercise, stage I sarcopenic obesity, Body Composition, physical performance, Metabolism, Inflammation
Received: 21 Feb 2025; Accepted: 28 Jul 2025.
Copyright: © 2025 Wei, Zhang, Cui and Su. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hao Su, School of Sports and Human Sciences, Beijing Sport University, Beijing, 100084, Beijing Municipality, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.